Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
688.75
14.15 (2.1%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 2.1 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "688.75",
    "chg": 14.15,
    "chgp": "2.1%",
    "dir": 1,
    "prev_price": "674.60",
    "mcapval": "6,232.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0LRU01027",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "07:50 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "2.1 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4134729",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiPharmalabs_mojoScore_4134729.png",
        "date": "2026-08-04 10:11:02",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4119026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiPharmalabs_mojoScore_4119026.png",
        "date": "2026-07-24 10:10:56",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-by-marketsmojo-4098221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiPharmalabs_mojoScore_4098221.png",
        "date": "2026-07-13 10:11:00",
        "description": "Aarti Pharmalabs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4084641",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiPharmalabs_mojoScore_4084641.png",
        "date": "2026-07-02 10:11:12",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aarti Pharmalabs Gains 0.04%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-gains-004-3-key-factors-driving-the-weeks-mixed-momentum-4075119",
        "imagepath": "",
        "date": "2026-06-27 11:01:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>22 Jun:</strong> Stock declined 2.00% to Rs.677.35 amid bearish technical momentum</p>\n                    <p><strong>23 Jun:</strong> Intraday high of Rs.735 reached with a 4.98% daily gain</p>\n                    <p><strong>24 Jun:</strong> Minor dip of 0.06% to Rs.710.65 on low volume</p>\n                    <p><strong>25 Jun:</strong> Stock fell 2.69% to Rs.691.50, closing near week’s open</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.691.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"s..."
      },
      {
        "title": "Aarti Pharmalabs Ltd Surges 7.53% to Day's High of Rs 735 — Outperforms Sector by 6.13 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-hits-intraday-high-with-753-surge-on-23-jun-2026-4068826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_priceRelatedfactors_4068826.png",
        "date": "2026-06-23 10:02:34",
        "description": "The Sensex edged up 0.10% on 23 Jun 2026, while Aarti Pharmalabs Ltd surged 7.53% to touch an intraday high of Rs 735, outperforming its Pharmaceuticals &amp; Biotechnology sector by 6.13 percentage points. This sharp single-session gain stands out as a significant stock-specific event amid a broadly positive but modest market advance."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4068236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4068236.png",
        "date": "2026-06-23 08:07:58",
        "description": "Aarti Pharmalabs Ltd has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook as of mid-June 2026. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, reflecting both caution and pockets of bullishness amid broader market pressures."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4066695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4066695.png",
        "date": "2026-06-22 08:03:39",
        "description": "Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a 5.01% gain on 22 Jun 2026, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4065997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_mojoScore_4065997.png",
        "date": "2026-06-21 10:10:35",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 316,
    "sid": "1003784",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Aug-2026",
      "details": "This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Monday August 10 2026 at 4:00 p.m. (IST) to discuss the Companys Q1-FY27 Financial Results.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026.",
      "datetime": "28-Jul-2026",
      "details": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "07 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26",
          "dt": "2026-02-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Aarti Pharmalabs Gains 0.04%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-06-27 11:01:42

Key Events This Week

22 Jun: Stock declined 2.00% to Rs.677.35 amid bearish technical momentum

23 Jun: Intraday high of Rs.735 reached with a 4.98% daily gain

24 Jun: Minor dip of 0.06% to Rs.710.65 on low volume

25 Jun: Stock fell 2.69% to Rs.691.50, closing near week’s open

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

03-Aug-2026 | Source : BSE

This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Monday August 10 2026 at 4:00 p.m. (IST) to discuss the Companys Q1-FY27 Financial Results.

Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026.

28-Jul-2026 | Source : BSE

Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30 2026.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Jul-2026 | Source : BSE

Please find enclosed

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

07 Aug 2026

stock-summary
DIVIDEND

Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available